000 01393 a2200385 4500
005 20250517071017.0
264 0 _c20161020
008 201610s 0 0 eng d
022 _a1872-7654
024 7 _a10.1016/j.ejogrb.2015.11.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrhut, Jan
245 0 0 _aImpact of body mass index on treatment efficacy of mirabegron for overactive bladder in females.
_h[electronic resource]
260 _bEuropean journal of obstetrics, gynecology, and reproductive biology
_cJan 2016
300 _a64-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetanilides
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aBody Mass Index
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aRisk Factors
650 0 4 _aThiazoles
_xtherapeutic use
650 0 4 _aTreatment Outcome
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
650 0 4 _aUrological Agents
_xtherapeutic use
700 1 _aMartan, Alois
700 1 _aZachoval, Roman
700 1 _aHanuš, Tomáš
700 1 _aŠvabík, Kamil
700 1 _aZvara, Peter
773 0 _tEuropean journal of obstetrics, gynecology, and reproductive biology
_gvol. 196
_gp. 64-8
856 4 0 _uhttps://doi.org/10.1016/j.ejogrb.2015.11.018
_zAvailable from publisher's website
999 _c25556475
_d25556475